Abbott’s FreeStyle Libre® Technology Linked to Dramatic Drop in Heart-Related Hospitalizations for People with Diabetes
Real-world data shows 78% reduction in cardiovascular complications for Type 1 diabetes…
Shame and stigma prevent many from managing diabetes, survey finds
February 2025- 'One cupcake won't kill you,' 'I'm going to get diabetes…
PHRMAG appoints new Executive Committee for 2025–2027
Dubai, UAE- February 2025- The Pharmaceutical Research and Manufacturers Association Gulf (PHRMAG)…
Abbott Unveils World-First Leadless Pacing in Heart’s Left Bundle
ABBOTT PARK, Ill., December 2024 - Abbott (NYSE: ABT) announced the successful completion…
Medlab Middle East 2025 to spotlight the rise of patient-centric healthcare
Dubai, UAE- December 2024- Patient consumerisation is transforming the healthcare industry worldwide…
Abbott Enhances Heart Failure Care with Aspirin-Free Regimen for HeartMate 3™ Patients
ABBOTT PARK, Ill.— Abbott recently announced that the U.S. Food and Drug…
Abbott and Medtronic team up for smarter diabetes care
August 2024- Abbott announced a unique global partnership with Medtronic to collaborate…
Abbott Receives CE Mark For AVEIR™ Dual Chamber
Abbott Park- June 2024- Abbott announced it has received CE Mark in…
Continuous Glucose Monitoring: Say Goodbye to Finger Pricks
2014 was not the same as 2004, and 2024 is not the…
Abbott’s Breakthrough Dissolving Stent Receives FDA Approval
May 2024- Abbott announced that the U.S. Food and Drug Administration (FDA)…